Related Experiment Video
Updated: Jul 19, 2026
09:58
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Leukotrienes and isocyanate-induced asthma: a pilot study.
C Lemiere1, S Pelissier, C Tremblay
1Department of Chest Medicine, Hôpital du Sacré-Coeur, Montreal, University of Montreal, QC, Canada. lemierec@crhsc.umontreal.ca
Summary
Isocyanate exposure triggers airway inflammation in asthma patients, increasing leukotriene B4 (LTB4) and IL-8 release. This study clarifies the role of leukotrienes in occupational asthma.
Area of Science:
- Immunology
- Occupational Medicine
- Respiratory Medicine
Background:
- The role of leukotrienes (LTs) in isocyanate-induced asthma pathophysiology is not well understood.
- Isocyanates are common triggers for occupational asthma.
Purpose of the Study:
- To characterize airway inflammation from isocyanate exposure.
- To investigate changes in leukotriene receptor expression and mediator release in response to isocyanates.
- To compare responses between asthmatics and healthy subjects.
Main Methods:
- Eight subjects with isocyanate-induced asthma and eight healthy subjects underwent isocyanate inhalation challenges.
- Sputum was collected pre- and post-exposure.
- Flow cytometry assessed cysteinyl leukotriene (CysLT1, CysLT2) and leukotriene B4 receptor (BLT1) expression.
- Enzyme immunoassay measured leukotriene (LTC4, LTB4) and IL-8 levels.
Main Results:
- Isocyanate exposure increased sputum neutrophils, CysLT1 and BLT1 receptor expression, LTB4, and IL-8 in asthmatics only.
- No significant changes in leukotriene mediators or receptor expression were observed in healthy subjects.
- LTC4 levels did not increase in either group.
Conclusions:
- Neutrophilia in isocyanate-induced asthma is linked to LTB4 release, potentially mediated by increased BLT1 expression and IL-8.
- The role of elevated CysLT1 receptor expression warrants further investigation.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...